71 related articles for article (PubMed ID: 8615013)
1. Analysis of HPV1 E4 complexes and their association with keratins in vivo.
Doorbar J; Medcalf E; Napthine S
Virology; 1996 Apr; 218(1):114-26. PubMed ID: 8615013
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells.
Roberts S; Ashmole I; Johnson GD; Kreider JW; Gallimore PH
Virology; 1993 Nov; 197(1):176-87. PubMed ID: 8212552
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization.
Wang Q; Griffin H; Southern S; Jackson D; Martin A; McIntosh P; Davy C; Masterson PJ; Walker PA; Laskey P; Omary MB; Doorbar J
J Virol; 2004 Jan; 78(2):821-33. PubMed ID: 14694114
[TBL] [Abstract][Full Text] [Related]
4. Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.
Knight GL; Turnell AS; Roberts S
J Virol; 2006 Aug; 80(15):7416-26. PubMed ID: 16840322
[TBL] [Abstract][Full Text] [Related]
5. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.
Doorbar J; Ely S; Sterling J; McLean C; Crawford L
Nature; 1991 Aug; 352(6338):824-7. PubMed ID: 1715519
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium.
Bryan JT; Han A; Fife KH; Brown DR
Virology; 2000 Mar; 268(2):430-9. PubMed ID: 10704351
[TBL] [Abstract][Full Text] [Related]
7. E1--E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium.
McIntosh PB; Laskey P; Sullivan K; Davy C; Wang Q; Jackson DJ; Griffin HM; Doorbar J
J Cell Sci; 2010 Aug; 123(Pt 16):2810-22. PubMed ID: 20663917
[TBL] [Abstract][Full Text] [Related]
8. The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus.
Doorbar J; Elston RC; Napthine S; Raj K; Medcalf E; Jackson D; Coleman N; Griffin HM; Masterson P; Stacey S; Mengistu Y; Dunlop J
J Virol; 2000 Nov; 74(21):10081-95. PubMed ID: 11024137
[TBL] [Abstract][Full Text] [Related]
9. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4.
Doorbar J; Foo C; Coleman N; Medcalf L; Hartley O; Prospero T; Napthine S; Sterling J; Winter G; Griffin H
Virology; 1997 Nov; 238(1):40-52. PubMed ID: 9375007
[TBL] [Abstract][Full Text] [Related]
10. Association of the human papillomavirus type 11 E1()E4 protein with cornified cell envelopes derived from infected genital epithelium.
Bryan JT; Brown DR
Virology; 2000 Nov; 277(2):262-9. PubMed ID: 11080474
[TBL] [Abstract][Full Text] [Related]
11. Virus-like particles and E1-E4 protein expressed from the human papillomavirus type 11 bicistronic E1-E4-L1 transcript.
Brown DR; Pratt L; Bryan JT; Fife KH; Jansen K
Virology; 1996 Aug; 222(1):43-50. PubMed ID: 8806486
[TBL] [Abstract][Full Text] [Related]
12. The E4 protein; structure, function and patterns of expression.
Doorbar J
Virology; 2013 Oct; 445(1-2):80-98. PubMed ID: 24016539
[TBL] [Abstract][Full Text] [Related]
13. The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.
Roberts S; Hillman ML; Knight GL; Gallimore PH
J Virol; 2003 Jan; 77(1):673-84. PubMed ID: 12477870
[TBL] [Abstract][Full Text] [Related]
14. Cytopathic effect in human papillomavirus type 1-induced inclusion warts: in vitro analysis of the contribution of two forms of the viral E4 protein.
Rogel-Gaillard C; Pehau-Arnaudet G; Breitburd F; Orth G
J Invest Dermatol; 1993 Dec; 101(6):843-51. PubMed ID: 7504028
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells.
Roberts S; Ashmole I; Gibson LJ; Rookes SM; Barton GJ; Gallimore PH
J Virol; 1994 Oct; 68(10):6432-45. PubMed ID: 7521917
[TBL] [Abstract][Full Text] [Related]
16. The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.
Bell I; Martin A; Roberts S
J Virol; 2007 Jun; 81(11):5437-48. PubMed ID: 17360743
[TBL] [Abstract][Full Text] [Related]
17. Keratin modifications and solubility properties in epithelial cells and in vitro.
Omary MB; Ku NO; Liao J; Price D
Subcell Biochem; 1998; 31():105-40. PubMed ID: 9932491
[TBL] [Abstract][Full Text] [Related]
18. Characterization of early assembly intermediates of recombinant human keratins.
Herrmann H; Wedig T; Porter RM; Lane EB; Aebi U
J Struct Biol; 2002; 137(1-2):82-96. PubMed ID: 12064936
[TBL] [Abstract][Full Text] [Related]
19. Epitope-mapped monoclonal antibodies against the HPV16E1--E4 protein.
Doorbar J; Ely S; Coleman N; Hibma M; Davies DH; Crawford L
Virology; 1992 Mar; 187(1):353-9. PubMed ID: 1371027
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the human papillomavirus type 16 E1--E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments.
Roberts S; Ashmole I; Rookes SM; Gallimore PH
J Virol; 1997 May; 71(5):3554-62. PubMed ID: 9094627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]